Intrathecal Morphine for Recovery and Outcomes After VATS

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorAtaturk University

About this trial

This study will compare two different methods of pain management in patients undergoing video-assisted thoracoscopic surgery (VATS). One group will receive a combination of spinal morphine, nerve block, and dexmedetomidine, while the other group will receive a nerve block and dexmedetomidine without spinal morphine. All patients will receive standard pain medications after surgery. The purpose is to see if adding spinal morphine improves pain control and recovery after surgery.

Eligibility criteria

Qualifiers

Elective video-assisted thoracoscopic surgery (VATS) planned

Age 18-70 years

ASA physical status I-III

Body mass index (BMI) <35 kg/m²

Disqualifiers

Coagulopathy

Opioid dependence or intolerance

Allergy to local anesthetics

Contraindications to neuraxial blockade

Trial design

Treatments tested in this trial

  • Intrathecal Morphine
  • Serratus Anterior Plane Block (SAPB) group
  • Dexmedetomidine

Treatment groups

52 Participants
are divided into 2 treatment groups

Sponsors and collaborators